Pulmonary Fibrosis Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GNOM | F | Global X Genomics & Biotechnology ETF | 5.24 | |
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 5.16 | |
EDOC | B | Global X Telemedicine & Digital Health ETF | 3.72 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 3.28 | |
WDNA | F | WisdomTree BioRevolution Fund | 2.29 |
Compare ETFs
- Pulmonary Fibrosis
Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.Causes include environmental pollution, certain medications, connective tissue diseases, infections (including SARS infections), interstitial lung diseases. Idiopathic pulmonary fibrosis (IPF), an interstitial lung disease of unknown cause, is most common. Diagnosis may be based on symptoms, medical imaging, lung biopsy, and lung function tests.There is no cure and there are limited treatment options available. Treatment is directed towards efforts to improve symptoms and may include oxygen therapy and pulmonary rehabilitation. Certain medications may be used to try to slow the worsening of scarring. Lung transplantation may occasionally be an option. At least 5 million people are affected globally. Life expectancy is generally less than five years.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles